Peregrine Pharmaceuticals (PPHM) Reports In-Line Q2 Loss of 5c/Share
Tweet Send to a Friend
Peregrine Pharmaceuticals (NASDAQ: PPHM) reported Q2 EPS of ($0.05) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
